About: Anemia and transfusion therapy: an update

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Anemia and transfusion therapy: an update Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Anemia and transfusion therapy: an update
Creator	Alonso-Fernández, G García-Barrasa, A Madrazo-González, Z Rafecas-Renau, A Rodríguez-Lorenzo, L
Source	Elsevier; PMC
abstract	Abstract Anemia is one of the most prevalent diseases in the general population and is a very frequently found condition in medical and surgical patients in all medical specialties. A good evaluation of its clinical impact and its therapeutic possibilities is essential. Allogenic blood transfusion is a useful procedure in anemia management, although it has important adverse effects. It is the responsibility of the clinician to know and to take into account all the available alternatives for the treatment of anemia. Blood transfusions, erythropoiesis-stimulating agents, iron therapy (oral and endovenous) and other therapeutic alternatives must be rationally used, in accordance with the currently available clinical evidence. This review article summarizes some epidemiological characteristics of anemia, its clinical evaluation and the main therapeutic possibilities based on the present knowledge, placing special emphasis on the critically ill patient.
has issue date	2011-12-31(xsd:dateTime)
bibo:doi	10.1016/s2173-5727(11)70007-8
has license	els-covid
sha1sum (hex)	c880b64455fea01451ca20519ed5d84f8c0c493d
schema:url	https://doi.org/10.1016/s2173-5727%2811%2970007-8
resource representing a document's title	Anemia and transfusion therapy: an update
has PubMed Central identifier	PMC7147130
schema:publication	Medicina Intensiva (English Edition)
resource representing a document's body	covid:c880b64455fea01451ca20519ed5d84f8c0c493d#body_text
is schema:about of	named entity 'THERAPY' named entity 'TRANSFUSION' named entity 'ANEMIA' named entity 'UPDATE' named entity 'medicina' named entity 'Anemia' named entity 'allergic reactions' named entity 'erythropoiesis' named entity 'angiotensin-converting enzyme inhibitors' named entity 'adverse effects' named entity 'inflammatory bowel disease' named entity 'latent viruses' named entity 'bone marrow' named entity 'hemoglobin' named entity 'adverse effects' named entity 'long-term' named entity 'signs and symptoms' named entity 'synergic' named entity 'ESA' named entity 'ESA' named entity 'endogenous' named entity 'dyspnea' named entity 'TRALI' named entity 'mediastinitis' named entity 'transfusion' named entity 'iron deficiency' named entity 'anemia' named entity 'brain metabolism' named entity 'bacteria' named entity 'oncological surgery' named entity 'mucosal' named entity 'iron supplements' named entity 'febrile' named entity 'severe anemia' named entity 'purpura' named entity 'anemia' named entity 'red cell' named entity 'hemoglobin' named entity 'vomiting' named entity 'allergic reactions' named entity 'parenteral' named entity 'morphological' named entity 'prognosis' named entity 'hemolytic' named entity 'aprotinin' named entity 'transfusion' named entity 'neoplastic' named entity 'iron therapy' named entity 'anemia' named entity 'Aprotinin' named entity 'transfusion' named entity 'neoplastic' named entity 'laboratory test' named entity 'microcirculation' named entity 'plasmin' named entity 'hemostatic agents' named entity 'chronic disease' named entity 'quality of life' named entity 'cardiovascular' named entity 'ESAs' named entity 'EPO' named entity 'lipids' named entity 'parvovirus B19' named entity 'toxicity' named entity 'pharmacological' named entity 'American Society of Clinical Oncology' named entity 'lung' named entity 'halflife' named entity 'antifibrinolytic' named entity 'ESAs' named entity 'allogenic' named entity 'desmopressin' named entity 'thromboembolism' named entity 'neoplastic' named entity 'adverse effects' named entity 'fluorocarbonate' named entity 'hemostatic agents' named entity 'trauma patients' named entity 'erythropoiesis'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software